VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,267,000 | -2.2% | 266,000 | 0.0% | 0.05% | 0.0% |
| Q4 2019 | $4,365,000 | +21.3% | 266,000 | -1.8% | 0.05% | -2.1% |
| Q3 2019 | $3,599,000 | -5.3% | 271,000 | 0.0% | 0.05% | +2.1% |
| Q2 2019 | $3,802,000 | -23.8% | 271,000 | 0.0% | 0.05% | -26.6% |
| Q1 2019 | $4,987,000 | +7.2% | 271,000 | +52.2% | 0.06% | -9.9% |
| Q4 2018 | $4,651,000 | +67.8% | 178,000 | +4.7% | 0.07% | +36.5% |
| Q2 2017 | $2,771,000 | -16.5% | 170,000 | -28.3% | 0.05% | -18.8% |
| Q1 2017 | $3,318,000 | -12.2% | 237,000 | 0.0% | 0.06% | -26.4% |
| Q4 2016 | $3,780,000 | +4.7% | 237,000 | +9.2% | 0.09% | 0.0% |
| Q3 2016 | $3,611,000 | – | 217,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |